Document:

Form of 1.875% Senior Subordinated Convertible Notes due 2017.

 Exhibit 4.2 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE
OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. THIS SECURITY IS A GLOBAL SECURITY
WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE
ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND, UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE
DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. 

 BIOMARIN PHARMACEUTICAL INC.

 1.875% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2017

 NO. A1 CUSIP: 09061G AD3 
 BioMarin Pharmaceutical Inc., a Delaware corporation, promises to pay to Cede & Co. or registered assigns the principal amount of Three Hundred Twenty Four Million Eight Hundred Seventy Five Thousand Dollars
($324,875,000) on April 23, 2017. 
  

			
	Interest Payment Dates:	  	April 23 and October 23,
		  	commencing October 23, 2007
	Record Dates:	  	April 8 and October 8

 This Security shall bear interest as specified on the other side of this Security. This Security
is convertible as specified on the other side of this Security. 
 Additional provisions of this Security are set forth on the other side of
this Security. 
 Dated: April 23, 2007 
 [SIGNATURE PAGE FOLLOWS] 
  

 Promise to Pay - 1 of 2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed as of April 23, 2007.

  

							
	BioMarin Pharmaceutical Inc.	  		  	
				
	By:	 		  		  	
			
	  
	  		  	
				
	By:	 		  		  	
			
	  
	  		  	
			
	Trustee’s Certificate of Authentication:	  		  	
			
	This is one of the Securities referred to in the within-mentioned Indenture.	  		  	
			
	Wilmington Trust Company, as Trustee	  		  	
				
	By:	 		  		  	
				
		 	  
	  		  	
		 	Authorized Signatory:	  		  	

  

 Promise to Pay - 2 of 2 

 BIOMARIN PHARMACEUTICAL INC.

 1.875% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2017

  

	1.	INTEREST 

 The Company promises to pay interest on the
principal amount of this Note at the rate of 1.875% per annum. The Company shall pay interest semiannually in arrears on April 23 and October 23 of each year (each, an “Interest Payment Date”), commencing on October 8,
2007. Interest on the Notes shall accrue from the most recent date to which interest has been paid or, if no interest has been paid, from April 23, 2007; provided, however, that if there is not an existing default in the payment of
interest and if this Note is authenticated between a record date referred to on the face hereof and the next succeeding Interest Payment Date, such Interest Payment Date. Interest will be computed on the basis of a 360-day year composed of twelve
30-day months. 
 If the Holder elects to require the Company to repurchase this Security pursuant to Section 5 of this Security, on a
date that is after the Regular Record Date and prior to the corresponding Interest Payment Date, interest, including Special Interest, if any, accrued and unpaid hereon to, but not including, the applicable Fundamental Change Repurchase Date, will
be paid to the Holder in whose name the Securities are registered as of the close of business on the Regular Record Date immediately preceding the applicable Fundamental Change Repurchase Date. 
 A Holder of any Security at the close of business on a Regular Record Date shall be entitled to receive interest, including Special Interest, if any, on
such Security on the corresponding Interest Payment Date. A Holder of any Security which is converted after the close of business on a Regular Record Date and prior to the corresponding Interest Payment Date (other than any Security whose Maturity
is prior to such Interest Payment Date) shall be entitled to receive interest, including Special Interest, if any, on the principal amount of such Security, notwithstanding the conversion of such Security prior to such Interest Payment Date.
However, any such Holder which surrenders any such Security for conversion during the period between the close of business on such Regular Record Date and ending with the opening of business on the corresponding Interest Payment Date shall be
required to pay the Company an amount equal to the interest, including Special Interest, if any, on the principal amount of such Security so converted (but excluding any overdue interest, including Special Interest, if any, on the principal amount
of such Security so converted that exists at the time such Holder surrenders such Security for conversion), which is payable by the Company to such Holder on such Interest Payment Date, at the time such Holder surrenders such Security for
conversion. Notwithstanding the foregoing, any such Holder which surrenders for conversion any Security (a) with respect to which the Company has specified a Fundamental Change Repurchase Date that is after such Regular Record Date and on or
prior to the next succeeding Interest Payment Date, or (b) after the last Regular Record Date prior to the Final Maturity Date, in either case, shall be entitled to receive (and retain) such interest, including Special Interest, if any, and
need not pay the Company an amount equal to the interest, including Special Interest, if any, on the principal amount of such Security so converted at the time such Holder surrenders such Security for conversion. 
  

 Form of Reverse Side of Security 
 Page 1 

	2.	METHOD OF PAYMENT 

 The Company shall pay interest,
including Special Interest, if any, on this Security (except defaulted interest) to the person who is the Holder of this Security at the close of business on April 8 and October 8, as the case may be, (each, a “Regular Record
Date”) immediately preceding the related Interest Payment Date. The Holder must surrender this Security to a Paying Agent to collect payment of principal. The Company will pay principal and interest and Special Interest, if any, in money of the
United States that at the time of payment is legal tender for payment of public and private debts. The Company may pay principal and interest, including Special Interest, if any, in respect of any Certificated Security by check or wire transfer
payable in such money; provided, however, that a Holder with an aggregate principal amount in excess of $5,000,000 will be paid by wire transfer in immediately available funds at the election of such Holder if such Holder has provided wire
transfer instructions to the Trustee at least 10 Business Days prior to the Payment Date. The Company may mail an interest check to the Holder’s registered address. Notwithstanding the foregoing, so long as this Security is registered in the
name of a Depositary or its nominee, all payments hereon shall be made by wire transfer of immediately available funds to the account of the Depositary or its nominee. 
 Any wire transfer instructions received by the Trustee will remain in effect until revoked by the Holder. 
  

	3.	PAYING AGENT, REGISTRAR AND CONVERSION AGENT 

 Initially,
Wilmington Trust Company (the “Trustee,” which term shall include any successor trustee under the Indenture hereinafter referred to) will act as Paying Agent, Registrar and Conversion Agent. The Company may change any Paying Agent,
Registrar or Conversion Agent without notice to the Holder. The Company or any of its Subsidiaries may, subject to certain limitations set forth in the Indenture, act as Paying Agent or Registrar. 
  

	4.	INDENTURE, LIMITATIONS 

 This Security is one of a duly
authorized issue of Securities of the Company designated as its 1.875% Senior Subordinated Convertible Notes Due 2017 (the “Securities”), issued under an Indenture dated as of March 29, 2006 (the “Base Indenture”), as
supplemented by the Second Supplemental Indenture dated April 23, 2007 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Indenture”), between the Company and the Trustee. The terms of this
Security include those stated in the Indenture and those required by or made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended, as in effect on the date of the Indenture. This Security is subject to all such terms,
and the Holder of this Security is referred to the Indenture and said Act for a statement of them. 
 The Securities are senior subordinated
unsecured obligations of the Company limited to $324,875,000 in aggregate principal amount at maturity. The Indenture does not limit the incurrence of other debt of the Company or its existing or future Subsidiaries, secured or unsecured.

  

 Form of Reverse Side of Security 
 Page 2 

	5.	PURCHASE OF SECURITIES AT OPTION OF HOLDER UPON A FUNDAMENTAL CHANGE 

 If a Fundamental Change occurs, at the option of the Holder and subject to the terms and conditions of the Indenture, the Company shall become obligated to purchase for cash, subject to certain exceptions described in
the Indenture all or any part specified by the Holder (so long as the principal amount of such part is $1,000 or an integral multiple of $1,000) of the Securities held by such Holder on a date specified by the Company that is no later than 30 days
after the date of the Fundamental Change Company Notice, at a purchase price equal to 100% of the principal amount thereof together with unpaid interest, including Special Interest, if any, accrued to, but excluding, the Fundamental Change
Repurchase Date. A Fundamental Change Company Notice shall be given by the Company to the Holders as provided in the Second Supplemental Indenture. To exercise such repurchase right, a Holder must deliver to the Trustee a Fundamental Change
Repurchase Notice as provided in the Second Supplemental Indenture. 
  

	6.	CONVERSION 

 Subject to and upon compliance with the
provisions of the Indenture, a Holder may surrender for conversion any Security that is $1,000 principal amount or integral multiples thereof. 
 Subject to certain conditions provided for in the Second Supplemental Indenture, in certain circumstances, a Holder may receive an amount in Common Stock equal to the Make Whole Premium, in addition to the shares of Common Stock issuable
upon conversion of such Security. 
 The Conversion Rate shall be initially equal to 49.1171 shares of Common Stock per $1,000 principal
amount of Securities. The Conversion Rate shall be adjusted under certain circumstances as provided in the Indenture. 
 No fractional share
of Common Stock shall be issued upon conversion of a Security. Instead, the Company shall pay a cash adjustment as provided in the Indenture. 
  

	7.	SUBORDINATION 

 The Indebtedness evidenced by this Security
is, to the extent and in the manner provided in the Indenture, subordinated and subject in right of payment to the prior payment in full of all amounts then due on all Senior Debt of the Company; provided, however, that the Securities, the
Indebtedness represented thereby and the payment of the principal of and premium, if any, and interest on the Securities in all respects shall rank equally with, or prior to, all existing and future Indebtedness of the Company that is expressly
subordinated to any Senior Debt, and this Security is issued subject to such provisions of the Indenture with respect thereto. Each Holder of this Security, by accepting the same, (a) agrees to and shall be bound by such provisions,
(b) authorizes and directs the Trustee on such Holder’s behalf to take such action as may be necessary or appropriate to effectuate the subordination so provided and (c) appoints the Trustee such Holder’s attorney-in-fact for any
and all such purposes. 
  

 Form of Reverse Side of Security 
 Page 3 

	8.	DENOMINATIONS, TRANSFER, EXCHANGE 

 The Securities are in
registered form, without coupons, in denominations of $1,000 principal amount and integral multiples of $1,000 principal amount. A Holder may register the transfer of or exchange Securities in accordance with the Indenture. The Registrar may require
a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes or other governmental charges that may be imposed in relation thereto by law or permitted by the Indenture. 
  

	9.	PERSONS DEEMED OWNERS 

 The Holder of a Security may be
treated as the owner of it for all purposes. 
  

	10.	UNCLAIMED MONEY 

 If money for the payment of principal or
interest, including Special Interest, if any, remains unclaimed for two years, the Trustee and any Paying Agent will pay the money back to the Company at its written request, subject to applicable unclaimed property law and the provisions of the
Indenture. After that, Holders entitled to money must look to the Company for payment as general creditors unless an applicable abandoned property law designates another person. 
  

	11.	DISCHARGE PRIOR TO MATURITY. 

 Subject to certain
conditions contained in the Indenture, the Company may discharge its obligations under the Securities and the Indenture if (1) all of the Securities then outstanding shall become due and payable at their scheduled Maturity within one year, and
(2) the Company shall have deposited with the Trustee money and/or U.S. Government Obligations sufficient to pay the principal of, and premium, if any, and interest, including Special Interest, if any, on all of the outstanding Securities on
the date of Maturity. 
  

	12.	AMENDMENT, SUPPLEMENT AND WAIVER 

 The Indenture permits,
with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities under the Indenture at any time by the Company and the Trustee with
the consent of the Holders of a majority in aggregate principal amount of the Securities then outstanding (or such lesser amount as shall have acted at a meeting pursuant to the provisions of the Indenture). The Indenture also contains provisions
permitting the Holders of specified percentages in principal amount of the Securities at the time outstanding, on behalf of the Holders of all the Securities, to waive compliance by the Company with certain provisions of the Indenture and certain
past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon
registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security or such other Security. 
  

 Form of Reverse Side of Security 
 Page 4 

 No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or
impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and premium, if any, and interest, including Special Interest, if any, on this Security at the times, places and rate, and in the coin or currency,
herein prescribed or to convert this Security as provided in the Indenture. 
  

	13.	SUCCESSOR ENTITY 

 When a successor corporation assumes all
the obligations of its predecessor under the Securities and the Indenture in accordance with the terms and conditions of the Indenture, the predecessor corporation (except in certain circumstances specified in the Indenture) shall be released from
those obligations. 
  

	14.	DEFAULTS AND REMEDIES 

 Under the Indenture, an Event of
Default shall occur if: 
 (a) the Company shall fail to pay when due the principal or any Fundamental Change Repurchase Price of any
Security, including any Make-Whole Premium, when the same becomes due and payable whether at the Final Maturity Date, upon repurchase, acceleration or otherwise whether or not such payment is prohibited by Article 5 of the Second Supplemental
Indenture; or 
 (b) the Company shall fail to pay an installment of interest, including Special Interest, if any, on any of the Securities,
which failure continues for 30 days after the date when due whether or not such payment is prohibited by Article 5 hereof; or 
 (c) the
Company shall fail to deliver when due all shares of Common Stock, together with cash instead of fractional shares deliverable upon conversion of the Securities, which failure continues for 10 days; or 
 (d) the Company fails to perform or observe any other term, covenant or agreement contained in the Securities, the Second Supplemental Indenture or the
Base Indenture and the failure continues for a period of 60 days after written notice of such failure, requiring the Company to remedy the same, shall have been given to the Company by the Trustee or to the Company and the Trustee by the Holders of
at least 25% in aggregate principal amount of the then-outstanding Securities; or 
 (e) (i) the Company fails to make any payment by the end
of the applicable grace period, if any, after the maturity of any Indebtedness for borrowed money in an amount in excess of $10,000,000 or (ii) there is an acceleration of any Indebtedness for borrowed money in an amount in excess of
$10,000,000 because of a default with respect to such Indebtedness without such Indebtedness having been discharged or such acceleration having been cured, waived, rescinded or annulled, in the case of either (i) or (ii) above, for a
period of 30 days after written notice to the Company by the Trustee or to the Company and the Trustee by Holders of at least 25% in aggregate principal amount of the then-outstanding Securities; or 
 (f) the Company fails to provide a Fundamental Change Company Notice in accordance with Section 3.08 of the Second Supplemental Indenture; or

  

 Form of Reverse Side of Security 
 Page 5 

 (g) a court having jurisdiction enters (i) a decree or order for relief in respect of the Company in
an involuntary case or proceeding under any Bankruptcy Law or (ii) a decree or order adjudging the Company a bankrupt or insolvent, or approves as properly filed a petition seeking reorganization, arrangement, adjustment or composition of or in
respect of the Company under any applicable U.S. federal or state law, or appoints a Receiver of the Company or of any substantial part of its property, or orders the winding up or liquidation of its affairs, and the continuance of any such decree
or order for relief or any such other decree or order unstayed and in effect for a period of 60 consecutive days; or 
 (h) the Company
pursuant to or within the meaning of any Bankruptcy Law: 
 (1) commences as a debtor a voluntary case or proceeding; 
 (2) consents to the entry of an order for relief against it in an involuntary case or proceeding or the commencement of any case against it; 

(3) consents to the appointment of a Receiver of it or for all or substantially all of its property; 
 (4) makes a general assignment for the benefit of its creditors; 
 (5) files a petition in bankruptcy or answer or consent seeking reorganization or relief; or 
 (6) consents
to the filing of such a petition or the appointment of or taking possession by a Receiver. 
 The term “Bankruptcy Law” means Title
11 of the United States Code (or any successor thereto) or any similar federal or state law for the relief of debtors. The term “Receiver” means any receiver, trustee, assignee, liquidator, sequestrator or similar official under any
Bankruptcy Law. 
 If an Event of Default shall occur and be continuing, the principal of all the Securities may be declared due and payable
in the manner and with the effect provided in the Indenture. 
 Notwithstanding the foregoing or anything to the contrary set forth in the
Second Supplemental Indenture, to the extent elected by the Company, the sole remedy for an Event of Default relating to the failure to comply with the reporting obligations set forth in Section 6.05 of the Second Supplemental Indenture and for
any failure to comply with the requirements of Section 314(a)(1) of the Trust Indenture Act, will for the first 180 days after the occurrence of such an Event of Default consist exclusively of the right to receive special interest on the
Securities at an annual rate equal to 1.0% of the principal amount of the Securities (“Special Interest”). The Special Interest will accrue on all outstanding Securities from and including the date on which an Event of Default relating to
a failure to comply with the reporting obligations set forth in Section 6.05 of the Second Supplemental Indenture first occurs to but not including the 180th day thereafter (or such earlier date on which the Event of Default shall have been
cured or waived). On such 180th day (or earlier, if the Event of Default relating to the reporting obligations is cured or waived prior to such 180th day), such Special Interest will cease to accrue 

  

 Form of Reverse Side of Security 
 Page 6 

 
and, if the Event of Default relating to reporting obligations has not been cured or waived prior to such 180th day, the Securities will be subject to
acceleration as provided for in Section 8.02 of the Second Supplemental Indenture. In the event the Company does not elect to pay Special Interest upon an Event of Default in accordance with this paragraph, the Securities will be subject to
acceleration as provided for above. If the Company elects to pay Special Interest as the sole remedy an Event of Default relating to the failure to comply with reporting obligations in Section 6.05 of the Second Supplemental Indenture or for
any failure to comply with the requirements of Section 314(a)(1) of the Trust Indenture Act in, the Company will notify all Holders, the Trustee and Paying Agent of such election on or before the close of business on the date on which such
Event of Default first occurs. 
  

	15.	TRUSTEE DEALINGS WITH THE COMPANY 

 Wilmington Trust
Company, the initial Trustee under the Indenture, in its individual or any other capacity, may make loans to, accept deposits from and perform services for the Company or an Affiliate of the Company, and may otherwise deal with the Company or an
Affiliate of the Company, as if it were not the Trustee. 
  

	16.	NO RECOURSE AGAINST OTHERS 

 A director, officer, employee
or shareholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture nor for any claim based on, in respect of or by reason of such obligations or their creation. The Holder of
this Security by accepting this Security waives and releases all such liability. The waiver and release are part of the consideration for the issuance of this Security. 
  

	17.	AUTHENTICATION 

 This Security shall not be valid until the
Trustee or an authenticating agent manually signs the certificate of authentication on the other side of this Security. 
  

	18.	ABBREVIATIONS AND DEFINITIONS 

 Customary abbreviations may
be used in the name of the Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian) and UGMA (= Uniform
Gifts to Minors Act). 
 All terms defined in the Indenture and used in this Security but not specifically defined herein are defined in the
Indenture and are used herein as so defined. 
  

	19.	CUSIP NUMBERS. 

 Pursuant to a recommendation promulgated
by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on this Security. No representation is made as to the accuracy of such numbers either as printed on this Security and reliance may be
placed only on the other identification numbers placed thereon. 
  

 Form of Reverse Side of Security 
 Page 7 

	20.	INDENTURE TO CONTROL; GOVERNING LAW 

 In the case of any
conflict between the provisions of this Security and the Indenture, the provisions of the Indenture shall control. This Security and the Indenture shall be governed by, and construed in accordance with, the laws of the State of New York. 

The Company will furnish to any Holder, upon written request and without charge, a copy of the Indenture. Requests may be made to: BioMarin
Pharmaceutical Inc. 105 Digital Drive, Novato, California 94949, Attention: Corporate Counsel, Facsimile No.: (415) 382-7889, Telephone No.: (415) 506-6307. 
  

 Form of Reverse Side of Security 
 Page 8 

 ASSIGNMENT FORM 
 To assign this Security, fill in the form below: 
 I or we assign and transfer this Security to 
  

					
	  

	(Insert assignee’s soc. sec. or tax I.D. no.)
	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code) and irrevocably appoint
	
	  

	Agent to transfer this Security on the books of the Company. The agent may substitute another to act for him or her.

  

									
	Date:	 	  
	 	Your Signature:	 	  

		 		 		  		 	(Sign exactly as your name appears on the other side of this Security)
				
	*Signature guaranteed by:	 		  		 	
			
	By:	 	  
	 	

	*	The signature must be guaranteed by an institution which is a member of one of the following recognized signature guaranty programs: (i) the Securities Transfer Agent Medallion
Program (STAMP); (ii) the New York Stock Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

  

 Assignment Form 

 CONVERSION NOTICE 
 To convert this Security, check the box: 
  ̈ 
 To convert only part of this Security, state the principal amount to be converted
(must be $1,000 or an integral multiple of $1,000): $            . 
 If you want the cash
paid to another person or the stock certificate made out in another person’s name, fill in the form below: 
  

	
	  

	(Insert assignee’s soc. sec. or tax I.D. no.)
	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code) and irrevocably appoint
	
	  

	Agent to transfer this Security on the books of the Company. The agent may substitute another to act for him or her.

  

									
	Date:	 	  
	 	Your Signature:	 	  

		 		 		  		 	(Sign exactly as your name appears on the other side of this Security)
				
	*Signature guaranteed by:	 		  		 	
			
	By:	 	  
	 	

	*	The signature must be guaranteed by an institution which is a member of one of the following recognized signature guaranty programs: (i) the Securities Transfer Agent Medallion
Program (STAMP); (ii) the New York Stock Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

  

 Conversion Notice 

 FUNDAMENTAL CHANGE REPURCHASE NOTICE 
  

	To:	BioMarin Pharmaceutical Inc. 

 The undersigned registered
owner of this Security hereby irrevocably acknowledges receipt of a notice from BioMarin Pharmaceutical Inc. (the “Company”) as to the occurrence of a Fundamental Change with respect to the Company and requests and instructs the Company to
purchase the entire principal amount of this Security, or the portion thereof (which is $1,000 or an integral multiple thereof) below designated, in accordance with the terms of the Indenture referred to in this Security at the Fundamental Change
Repurchase Price to the registered Holder hereof. 
  

							
	Date:	 	  
	  	Your Signature:	 	  

	
	Signature(s) must be guaranteed by a qualified guarantor institution with membership in an approved signature guarantee program pursuant to Rule 17Ad-15 under the Securities Exchange
Act of 1934.
	
	  

	Signature Guaranty

 Principal amount to be repurchased (in an integral multiple of $1,000, if less than all): 
 NOTICE: The signature to the foregoing Election must correspond to the Name as written upon the face of this Security in every particular, without any alteration or
change whatsoever. 
  

 Fundamental Change Repurchase Notice 

 SCHEDULE OF EXCHANGES OF SECURITIES 
 The following exchanges, purchase, repurchases, purchases or conversions of a part of this Global Security have been made: 
  

									
	 Date of Exchange
	  	Amount of
Decrease in
Principal
Amount of this
Security	  	Amount of
Increase in
Principal
Amount of this
Security	  	Principal
Amount of this
Global Security
following Each
Increase or
Decrease	  	Signature of
Authorized
Officer of
Trustee
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  

 Schedule of Exchanges of Securities2004 Restricted Stock Plan of the Company

 Exhibit 10(f)(2) 
 RESTRICTED STOCK AGREEMENT 
 CEC ENTERTAINMENT, INC. 2004 RESTRICTED STOCK PLAN 
  

					
	Grantee:	 	  	 	
	 Address:
	 	  	 	

  

			
	 Number of
 Awarded Shares:
	 	  
	 Grant Date:
	 	  

  

															
	Vesting of Awarded Shares:	 	 	 	Date	 	 	  	No. Shares	 	 	 	Vested %	 	 
	  	 		 	  	 		  	  	 		 	  	 	%                                    
								
	  	 		 	  	 		  	  	 		 	  	 	%
								
	  	 		 	  	 		  	  	 		 	  	 	%
								
	  	 		 	  	 		  	  	 		 	  	 	%
							
		 		 	Total	  		 		 	100%	 	

 CEC Entertainment, Inc., a Kansas corporation (the “Company”), hereby grants to the individual whose
name appears above (“Grantee”), pursuant to the provisions of the CEC Entertainment, Inc. 2004 Restricted Stock Plan, as amended from time to time in accordance with its terms (the “Plan”), a restricted stock award (this
“Award”) of shares (the “Awarded Shares”) of its common stock, par value $.10 per share (the “Common Stock”), effective as of the date of grant as set forth above (the “Grant Date”), upon and subject to the
terms and conditions set forth in this Restricted Stock Agreement (this “Agreement”) and in the Plan, which are incorporated herein by reference. Unless otherwise defined in this Agreement, capitalized terms used in this Agreement shall
have the meanings assigned to them in the Plan. 
 1. Effect of the Plan. The Awarded Shares granted to Grantee are subject to all of the provisions of the
Plan and of this Agreement, together with all rules and determinations from time to time issued by the Committee pursuant to the Plan. The Company, by action of the Committee or the Board, hereby reserves the right to alter, amend, revise, suspend,
or discontinue the Plan without the consent of Grantee, so long as such alteration, amendment, revision, suspension or discontinuance shall not adversely affect the rights and benefits available to Grantee hereunder, and this Award shall be subject,
without further action by the Company or Grantee, to such alteration, amendment, revision, suspension or discontinuance unless provided otherwise therein. 
 2. Grant. This Award shall evidence Grantee’s ownership of the Awarded Shares. Grantee agrees that the Awarded Shares shall be subject to all of the terms and conditions set forth in this Agreement and the Plan, including the
forfeiture conditions set forth in Section 4 of this Agreement, the restrictions on transfer set forth in Section 5 of this Agreement and the satisfaction of the Required Withholding as set forth in Section 8(a) of this Agreement.
Grantee 

  

 70 

 
acknowledges that he or she will not receive a stock certificate representing the Awarded Shares unless and until the Awarded Shares vest as provided in this
Award and all tax withholding obligations applicable to the Vested Awarded Shares (as defined below) have been satisfied. The Awarded Shares will be held in custody for Grantee, by the Company, until the Awarded Shares have vested in accordance with
Section 3 of this Award. In accordance with the terms of Section 12.8 of the Plan, the stock certificates for the Awarded Shares will be endorsed with the legends contained in such Section. Upon vesting of the Awarded Shares, the Company
shall, unless otherwise paid by Grantee as described in Section 8(a) of this Agreement, withhold that number of Vested Awarded Shares necessary to satisfy any applicable tax withholding obligation of Grantee in accordance with the provisions of
Section 8(a) of this Agreement, and thereafter shall deliver to Grantee all remaining Vested Awarded Shares. 
 3. Vesting Schedule; Service
Requirement. Except as provided otherwise in Section 4 of this Agreement, the Awarded Shares shall vest if the Grantee does not experience a Termination of Service during the period commencing with the Grant Date and ending with the applicable
date that such portion of the Awarded Shares vests (each, a “Vesting Date”). Termination of Service occurs when a Grantee ceases to serve as an employee of the Company or a Subsidiary for any reason (other than due to death or disability),
including, but not limited to, Grantee’s voluntary resignation or termination by the Company with or without cause. Awarded Shares that have vested pursuant to this Agreement are referred to herein as “Vested Awarded Shares” and
Awarded Shares that have not yet vested pursuant to this Agreement are referred to herein as “Unvested Awarded Shares.” Subject to the provisions of Section 4 of this Agreement, if the Grantee does not experience a Termination of
Service prior to an applicable Vesting Date, the Awarded Shares will vest in accordance with the Vesting Dates set forth on the first page of this Agreement under the heading “Vesting of Awarded Shares.” If an installment of the vesting
would result in a fractional Vested Awarded Share, such installment will be rounded to the next lower Awarded Share, as determined by the Company, except the final installment, which will be for the balance of the Awarded Shares. 
 4. Conditions of Forfeiture. 
 (a) Upon the effective date of Grantee’s
Termination of Service (the “Termination Date”) before all of the Awarded Shares become Vested Awarded Shares, all Unvested Awarded Shares as of the Termination Date shall, without further action of any kind by the Company or Grantee, be
forfeited. Unvested Awarded Shares that are forfeited shall be deemed to be immediately transferred to the Company without any payment by the Company or action by Grantee, and the Company shall have the full right to cancel any evidence of
Grantee’s ownership of such forfeited Unvested Awarded Shares and to take any other action necessary to demonstrate that Grantee no longer owns such forfeited Unvested Awarded Shares automatically upon such forfeiture. Following such
forfeiture, Grantee shall have no further rights with respect to such forfeited Unvested Awarded Shares. Grantee, by his acceptance of the Award granted pursuant to this Agreement, irrevocably grants to the Company a power of attorney to transfer to
the Company Unvested Awarded Shares 

  

 71 

 
that are forfeited and agrees to execute any documents requested by the Company in connection with such forfeiture and transfer. The provisions of this
Agreement regarding transfers of Unvested Awarded Shares that are forfeited shall be specifically performable by the Company in a court of equity or law. 
 (b) Notwithstanding anything to the contrary in this Agreement, the Unvested Awarded Shares shall become vested (i) on the death of Grantee while Grantee is still an employee of the Company or a Subsidiary, (ii) in accordance with
the provisions of Article 10 of the Plan relating to a Change in Control event, or (iii) or at the direction of the Committee in accordance with the provisions of Sections 6.6 and 6.10 of the Plan. 
 5. Non-Transferability. Grantee may not sell, transfer, pledge, exchange, hypothecate, or otherwise encumber or dispose of any of the Unvested Awarded Shares, or any
right or interest therein, by operation of law or otherwise. Any transfer in violation of this Section 5 shall be void and of no force or effect, and shall result in the immediate forfeiture of all Unvested Awarded Shares. The Company shall not
be required (i) to transfer on its books any Unvested Awarded Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or the Plan, or (ii) to treat as owner of such Unvested Awarded
Shares, or accord the right to vote or pay or deliver dividends or other distributions to, any purchaser or other transferee to whom or which such Unvested Awarded Shares shall have been so transferred. 
 6. Dividend and Voting Rights. Subject to the restrictions contained in this Agreement, Grantee shall have the rights of a stockholder with respect to the Awarded
Shares, including the right to vote all such Awarded Shares, including Unvested Awarded Shares, and to receive all dividends, paid or delivered thereon, from and after the date hereof. In the event of forfeiture of Unvested Awarded Shares, Grantee
shall have no further rights with respect to such Unvested Awarded Shares. However, the forfeiture of the Unvested Awarded Shares pursuant to Section 4 hereof shall not create any obligation to repay cash dividends received as to such Unvested
Awarded Shares, nor shall such forfeiture invalidate any votes given by Grantee with respect to such Unvested Awarded Shares prior to forfeiture. 
 7.
Capital Adjustments and Corporate Events. If, from time to time during the term of this Agreement, there is any capital adjustment affecting the outstanding Common Stock as a class without the Company’s receipt of consideration, the Unvested
Shares shall be adjusted in accordance with the provisions of the Plan. Any and all new, substituted or additional securities to which Grantee may be entitled by reason of Grantee’s ownership of the Unvested Awarded Shares hereunder because of
a capital adjustment shall be immediately subject to the forfeiture provisions of this Agreement and included thereafter as “Unvested Awarded Shares” for purposes of this Agreement. 
  

 72 

 8. Tax Matters. 
 (a) The
Company’s obligation to deliver Awarded Shares to Grantee upon the vesting of such shares shall be subject to the satisfaction of all applicable federal, state and local income and employment tax withholding requirements (the “Required
Withholding”). If the Company has not received from Grantee payment for the full amount of the Required Withholding within five (5) business days after the Company has notified the Grantee of the amount of such Required Withholding, the
Company shall withhold from the Vested Awarded Shares that otherwise would have been delivered to Grantee a number of Vested Awarded Shares of sufficient value necessary to satisfy Grantee’s Required Withholding, and deliver the remaining
Vested Awarded Shares to Grantee. The amount of the Required Withholding and the number of Vested Awarded Shares to be withheld by the Company, if applicable, to satisfy Grantee’s Required Withholding, as well as the amount reflected on tax
reports filed by the Company, shall be based on the value of the Vested Awarded Shares as of 12:01 A.M. Central Standard Time on the applicable Vesting Date. The obligations of the Company under this Award will be conditioned on such satisfaction of
the Required Withholding. 
 (b) Grantee acknowledges that the tax consequences associated with the Award are complex and that the Company has urged Grantee
to review with Grantee’s own tax advisors the federal, state, and local tax consequences of this Award. Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Grantee
understands that Grantee (and not the Company) shall be responsible for Grantee’s own tax liability that may arise as a result of the Award. Grantee understands further that Section 83 of the Internal Revenue Code of 1986, as amended (the
“Code”), taxes as ordinary income the fair market value of the Awarded Shares as of the Vesting Date. Grantee also understands that Grantee may elect to be taxed at Grant Date rather than at the time the Awarded Shares vest by filing an
election under Section 83(b) of the Code with the Internal Revenue Service and by providing a copy of the election to the Company. GRANTEE ACKNOWLEDGES THAT HE OR SHE HAS BEEN INFORMED OF THE AVAILABILITY OF MAKING AN ELECTION IN ACCORDANCE
WITH SECTION 83(b) OF THE CODE; THAT SUCH ELECTION MUST BE FILED WITH THE INTERNAL REVENUE SERVICE (AND A COPY OF THE ELECTION GIVEN TO THE COMPANY) WITHIN 30 DAYS OF THE GRANT OF AWARDED SHARES TO GRANTEE; AND THAT GRANTEE IS SOLELY RESPONSIBLE FOR
MAKING SUCH ELECTION. 
 9. Entire Agreement; Governing Law. The Plan and this Agreement constitute the entire agreement of the Company and Grantee
(collectively, the “Parties”) with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Parties with respect to the subject matter hereof. If there is any inconsistency between
the provisions of this Agreement and of the Plan, the provisions of the Plan shall govern. Nothing in the Plan and this Agreement (except as expressly provided therein or herein) is intended to confer any rights or remedies on any person other than
the Parties. The Plan and this Agreement are to be construed in accordance with and governed by the laws of the State of Texas, without giving effect to any choice-of-law rule that would cause the 

  

 73 

 
application of the laws of any jurisdiction other than the laws of the State of Texas to apply to the rights and duties of the Parties. Should any provision
of the Plan or this Agreement relating to the Shares be determined by a court of law to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective
and shall remain enforceable. 
 10. Amendment; Waiver. This Agreement may be amended or modified only by means of a written document or documents signed by
the Company and Grantee. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board or by the Committee. A waiver on one occasion shall not be deemed to be a
waiver of the same or any other breach on a future occasion. 
 11. Notice. Except for any notice provided pursuant to Section 8(a), any notice or other
communication required or permitted hereunder shall be given in writing and shall be deemed given, effective, and received upon prepaid delivery in person or by courier or upon the earlier of delivery or the third business day after deposit in the
United States mail if sent by certified mail, with postage and fees prepaid, addressed to the other Party at its address as shown beneath its signature in this Agreement, or to such other address as such Party may designate in writing from time to
time by notice to the other Party in accordance with this Section 11. 
 12. Lapse of Agreement. This Agreement shall be null and void in the event the
Grantee fails to sign and return a counterpart hereof to the Company within sixty (60) days of its delivery to the Grantee. 
  

			
	CEC ENTERTAINMENT, INC.
		
	 By:
	 	  
		
	 Name:
	 	  
		
	 Title:
	 	  

  

	
	 Address: 4441 West Airport Freeway

	
	                             Irving, Texas 75062

 GRANTEE ACKNOWLEDGES AND AGREES THAT THE SHARES SUBJECT TO THIS RESTRICTED STOCK AWARD SHALL VEST AND THE
FORFEITURE RESTRICTIONS SHALL LAPSE, IF AT ALL, ONLY DURING THE PERIOD OF GRANTEE’S EMPLOYMENT OR AS OTHERWISE PROVIDED IN THIS AGREEMENT. GRANTEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT OR THE PLAN SHALL CONFER UPON
GRANTEE ANY RIGHT WITH RESPECT TO FUTURE AWARDS OR CONTINUATION OF GRANTEE’S EMPLOYMENT. Grantee acknowledges receipt of a copy of the Plan, represents that he or she is generally familiar with the terms and provisions thereof, and hereby
accepts the Restricted Stock Award 

  

 74 

 
subject to all of the terms and provisions hereof and thereof. Grantee has reviewed this Agreement and the Plan in their entirety, has had an opportunity to
obtain the advice of counsel prior to executing this Agreement, and understands the provisions of this Agreement and the Plan. Grantee further agrees to notify the Company upon any change in the address for notice indicated in this Agreement.

  

			
	Signed:	 	  
		
	Print Name:	 	  
		
	Address:	 	  

  

 75

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]